Depression and Breast Cancer in Morocco: Prevalence and Associated Factors
Table 2
Main significant analytical results of the depression prevalence according to sociodemographic, clinical, and therapeutic characteristics of breast cancer patients.
Sample characteristics
Depression
No depression
value ()
%
%
Old (years)
20 to 40
8
57.1
6
42.9
0.004
41 to 60
18
25
54
75
0.715
>60
0
0
14
100
0.017
Psychiatric history
Yes
11
64.7
6
35.3
0.000
No
15
18.1
68
81.9
Stage (dissemination)
Local
2
8
23
92
0.018
Locoregional
11
21.6
40
78.4
0.303
Metastasis
13
54.2
11
45.8
0.000
Treatment refusal
Yes
2
100
0
0
0.016
No
24
24.5
74
75.5
Prognosis assessment by the patient
Curable
22
22.9
74
77.1
0.001
Not curable
4
100
0
0
Alteration of marital life
Yes
11
55
9
45
0.001
No
15
18.8
65
81.2
Loss of family responsibilities
Yes
11
52.4
10
47.6
0.002
No
15
29
64
81
Kind of treatment
Chemotherapy only
4
22.2
14
77.8
0.687
Surgery and chemotherapy
5
17.9
23
82.1
0.247
Surgery and radiotherapy
1
9.1
10
90.9
0.175
Surgery, chemotherapy, and radiotherapy
2
10
18
90
0.068
Surgery, chemotherapy, and hormonotherapy
4
80
1
20
0.005
Surgery, chemotherapy, radiotherapy, and hormonotherapy
10
55.6
8
44.4
0.002
Time to start treatment
<3 months
3
9.1
30
90.9
0.007
Between 3 months and 1 year
9
20.9
34
79.1
0.315
Between 1 year and 5 years
7
58.3
5
41.7
0.006
>5 years
7
58.3
5
41.7
0.006
Psychological care
Yes
2
100
0
0
0.016
No
24
24.5
74
75.5
0.007
Qualitative variables were expressed as headcount () and percentage (%); the bolded value means a significant value.
